Search

everythinglearnresearchcommunity

for

Search:↓

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

PCOS may have evolved as an advantage in past environments with food scarcity.

Recognizing new allergens can help reduce contact dermatitis cases.

Current treatments for androgenetic alopecia manage symptoms but don't cure it, and it affects social and psychological well-being.

Keratosis pilaris is a common skin condition where hair follicles get clogged with keratin, mostly on the arms and thighs.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Lower SHBG levels may increase the risk of PCOS.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.